NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and Nuclea Biotechnologies said this week they are collaborating on mass spec-based assays for quantification of native insulin and its therapeutic analogs.
NEW YORK (GenomeWeb News) – Nuclea Biotechnologies and Thermo Fisher Scientific said today that they are collaborating on multiplexed mass spec assays for quantifying native insulin and its therapeutic analogs.
NEW YORK (GenomeWeb News) – Nuclea Biotechnologies this week announced Immuno-Biological Laboratories will be the primary US distributor of Nuclea's HER-2/neu kits.
Nuclea and IBL also will coordinate joint marketing efforts for the serum HER-2/neu kits as part of the deal.
NEW YORK (GenomeWeb News) – The Massachusetts Life Sciences Center has released the list of firms that will receive a total of $25 million in tax incentives tied to job creation this year, and that list includes several omics and molecular diagnostics firms.